43 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
Here's Why CME Group (CME) Deserves a Spot in Your Portfolio https://www.zacks.com/stock/news/2212995/here-s-why-cme-group-cme-deserves-a-spot-in-your-portfolio?cid=CS-ZC-FT-analyst_blog|rank_focused-2212995 Jan 19, 2024 - CME Group's (CME) global presence, compelling product portfolio, focus on over-the-counter clearing services and effective capital deployment poise it well for growth.
What's in Store for Progressive (PGR) This Earnings Season? https://www.zacks.com/stock/news/2213576/what-s-in-store-for-progressive-pgr-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-2213576 Jan 22, 2024 - Progressive's (PGR) fourth-quarter earnings are likely to have benefited from improved rates, solid policies in force and higher retention in its strong Vehicle and Property businesses.
Is a Beat in Store for Marsh & McLennan (MMC) in Q4 Earnings? https://www.zacks.com/stock/news/2213662/is-a-beat-in-store-for-marsh-mclennan-mmc-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2213662 Jan 22, 2024 - Marsh & McLennan's (MMC) fourth-quarter results are likely to reflect robust international operations in the Risk and Insurance Services unit.
Chubb (CB) Q4 Earnings and Revenues Beat Estimates https://www.zacks.com/stock/news/2218351/chubb-cb-q4-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2218351 Jan 30, 2024 - Chubb (CB) delivered earnings and revenue surprises of 63.71% and 3.92%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Chubb (CB) Reports Q4 Earnings: What Key Metrics Have to Say https://www.zacks.com/stock/news/2218383/chubb-cb-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2218383 Jan 30, 2024 - Although the revenue and EPS for Chubb (CB) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Top Research Reports for Abbott, T-Mobile & Booking https://www.zacks.com/commentary/2219543/top-research-reports-for-abbott-t-mobile-booking?cid=CS-ZC-FT-research_daily-2219543 Feb 01, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) Booking Holdings Inc. (BKNG).
Top Research Reports for NVIDIA, Visa & Amgen https://www.zacks.com/commentary/2232860/top-research-reports-for-nvidia-visa-amgen?cid=CS-ZC-FT-research_daily-2232860 Feb 28, 2024 - Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Visa Inc. (V) and Amgen Inc. (AMGN).
Why Are Prudent Investors Favoring AMERISAFE (AMSF) Shares Now? https://www.zacks.com/stock/news/2234150/why-are-prudent-investors-favoring-amerisafe-amsf-shares-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2234150 Feb 29, 2024 - AMERISAFE's (AMSF) cost-saving initiatives are expected to drive bottom-line growth.
Chubb (CB) Shares Rise 21% in 6 months: Will the Bull Run Stay? https://www.zacks.com/stock/news/2244406/chubb-cb-shares-rise-21-in-6-months-will-the-bull-run-stay?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2244406 Mar 21, 2024 - A compelling portfolio, strong renewal retention, positive rate increases, strategic initiatives to fuel profitability and solid capital position continue to drive Chubb (CB).
Top Analyst Reports for Alphabet, Oracle & Chevron https://www.zacks.com/commentary/2249049/top-analyst-reports-for-alphabet-oracle-chevron?cid=CS-ZC-FT-research_daily-2249049 Apr 02, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Oracle Corporation (ORCL) and Chevron Corporation (CVX).

Pages: 12345

<<<Page 4